Please login to the form below

Not currently logged in
Email:
Password:

Conversis Medical names Mark Hooper global director

He brings 13 years' experience in pharma services to the role

Medical translation agency Conversis Medical has named Dr Mark Hooper as global director.

Dr Hooper has worked in the pharma services field for the past 13 years and has experience in both the contract research organisation (CRO) and contract manufacturing organisation (CMO) environments.

Gary Muddyman, founder of Conversis Medical, explained: “We aim to provide the pharmaceutical industry with a service that encompasses the unique requirements of this sector and Mark's appointment will help us achieve this.

“Mark's deep understanding of the pharma market will give us a real competitive advantage.”

Dr Hooper said: “Medical translation requires specialist knowledge of the translation/localisation process, in direct combination with the regulatory requirements of medicines and the specific scientific terms used for drug products.

“Language works only when the speaker and the audience, and the translators, share the same background knowledge and understand the context of communication.”

27th June 2014

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...

Latest intelligence

white house
Eliminating pharmaceutical rebates, is this déjà vu?
By Andrew Parece and Matthew Majewski...
Patients are ready to embrace decentralised clinical trials, are you?
Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid...
Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...

Infographics